Information  X 
Enter a valid email address

Biogen Inc Ord Shs (0R1B)

Date Time Source Announcement
18 Oct 2018 12:30 pm
GNW
Biogen to Present Data from Alzheimer’s Di...
17 Oct 2018 7:00 am
GNW
IMRALDI™, Biogen’s Adalimumab Biosimi...
11 Oct 2018 12:30 pm
GNW
Biogen Advances Research to Improve Outcomes fo...
06 Oct 2018 12:30 pm
GNW
New SPINRAZA® (nusinersen) Data Presented ...
03 Oct 2018 12:30 pm
GNW
Biogen to Present Data from its Neurology Pipel...
02 Oct 2018 12:30 pm
GNW
Biogen Highlights at ECTRIMS 2018 Data on Its I...
04 Sep 2018 12:30 pm
GNW
Biogen Enrolls First Patient in Global Phase 3 ...
28 Aug 2018 12:30 pm
GNW
Biogen and Eisai Report Data from Long-Term Ext...
25 Jul 2018 10:08 pm
GNW
Eisai and Biogen Announce Detailed Results of P...
  3:30 pm
GNW
Eisai and Biogen Present Detailed Results From ...
18 Jul 2018 12:30 pm
GNW
Data to be Presented From Biogen's Alzheimer's ...
06 Jul 2018 12:30 am
GNW
Eisai and Biogen Announce Positive Topline Resu...
28 Jun 2018 9:06 pm
GNW
Biogen Exercises Option to Increase Ownership i...
13 Jun 2018 12:30 pm
GNW
Biogen Enhances Commitment to SMA Research with...
07 Jun 2018 12:30 pm
GNW
Biogen Enters Exclusive Option Agreement to Acq...
31 May 2018 12:30 pm
GNW
Biogen Appoints Daniel Karp as EVP, Corporate D...
08 May 2007 7:00 am
RNS
Biogen Idec and Vernalis
  7:00 am
RNS
Biogen Idec and Vernalis
28 Sep 2006 2:31 pm
BUS
Research Update
14 Apr 2005 7:00 am
BUS
Positive One-Year Data From SENTINEL Trial
28 Feb 2005 1:16 pm
BUS
Biogen Idec and Elan Announce Voluntary Suspension
  1:16 pm
BUS
Biogen Idec and Elan Announce Voluntary Suspension
05 Jan 2005 7:00 am
RNS
Agreement with Biogen Idec
  7:00 am
RNS
Agreement with Biogen Idec
21 Dec 2004 1:08 pm
BUS
Biogen Idec and Elan Announce Head-to-Head
18 Aug 2004 7:45 am
PRN
Regulatory Update
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t